Associated Papers
Integrating evidence from protein domains to identify cancer driver mutations.
Ostroverkhova D et al.
Protein Science : a Publication of the Protein Society, 2026
41556616 (PubMed )
Supplement: PRO-35-e70422-s002.xlsx › Table_S1
Analysis of 1386 epileptogenic brain lesions reveals association with DYRK1A and EGFR.
Boßelmann CM et al.
Nature Communications, 2024
39616148 (PubMed )
Supplement: 41467_2024_54911_MOESM10_ESM.xlsx › Supplementary_Data_8
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes TK et al.
Nature Communications, 2024
38548752 (PubMed )
Supplement: 41467_2024_45594_MOESM4_ESM.xlsx › All
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
Schubert L et al.
Frontiers in Oncology, 2023
37168365 (PubMed )
Supplement: Table_4.xlsx › EGFR_mutations
A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.
Pappula AL et al.
Cancers, 2021
34503108 (PubMed )
Supplement: cancers-13-04299-s001.zip › Supplemental_Tables_final.xlsx › Table_S11
Finding driver mutations in cancer: Elucidating the role of background mutational processes.
Brown AL et al.
Plos Computational Biology, 2019
31034466 (PubMed )
Supplement: pcbi.1006981.s010.xlsx › final_benchmark
Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".
Purba ER et al.
Cells, 2017
Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo.
Greenall SA et al.
Oncogene, 2015
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics.
Alaoui-Jamali MA et al.
Frontiers in Genetics, 2015
25699077 (PubMed )
Supplement: Table1.PDF
Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro.
Puyo S et al.
Molecular Diagnosis & Therapy, 2008
Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
Choi JE et al.
Bmc Cancer, 2007
Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.
Sihto H et al.
Journal of Molecular Medicine (berlin, Germany), 2005
Select a paper to view details